These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 7797949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ, Dukers N, Krol A, van Ameijden EJ, van Leeuwen R, Roos MT, de Wolf F, Coutinho RA, Keet IP.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov 01; 19(3):254-9. PubMed ID: 9803967
    [Abstract] [Full Text] [Related]

  • 11. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.
    Vella S, Giuliano M, Floridia M, Chiesi A, Tomino C, Seeber A, Barcherini S, Bucciardini R, Mariotti S.
    AIDS; 1995 Jan 01; 9(1):51-6. PubMed ID: 7893441
    [Abstract] [Full Text] [Related]

  • 12. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC, Nielsen C, Gerstoft J, Nielsen CM, Vestergaard BF.
    Ugeskr Laeger; 1994 Jan 10; 156(2):185-6. PubMed ID: 7905217
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.
    Stein DS, Graham NM, Park LP, Hoover DR, Phair JP, Detels R, Ho M, Saah AJ.
    Ann Intern Med; 1994 Jul 15; 121(2):100-8. PubMed ID: 8017721
    [Abstract] [Full Text] [Related]

  • 17. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
    Graham NM, Piantadosi S, Park LP, Phair JP, Rinaldo CR, Fahey JL.
    J Acquir Immune Defic Syndr (1988); 1993 Nov 15; 6(11):1258-66. PubMed ID: 7901384
    [Abstract] [Full Text] [Related]

  • 18. Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
    Holmberg SD, Conley LJ, Buchbinder SP, Judson FN, Bush TJ, Katz MH, Penley KA, Hershow RC.
    AIDS; 1993 May 15; 7(5):699-704. PubMed ID: 8318177
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.